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Abstract: 
Hemagglutinin (HA) is the principal antigen, present on the viral surface. It is the primary target for neutralizing antibodies. In this paper, we 
have carried out studies on human hemagglutinin protein from H5N1 strain with homologous hemagglutinin from non-human sources of H5N1 
strains. In all strains, part of the antigenic site (128-141) predicted by computer program “Antigenic”, corresponds to immunodominant site Sa of 
H1 subtype. In AAF02304 strain, A156→S156 mutation lies at the antigenic subsite of site 2 that corresponds to site B in the H3 subtype. In 
some strains of non-human origins, there are mutations at the antigenic sites. Interestingly, in AAY56367 strain mutation L138→H138 lies at the 
receptor binding site, which also overlaps the antigenic site. Therefore, this amino acid substitution may influence both the specificity of receptor 
recognition and antibody binding. Seven potential glycosylation sites in human HA and in some strains of non-human sources have been 
predicted by computer program, Scan Prosite. In some strains of HA from non-human sources because of mutation, an additional glycosylation 
site appeared at the antigenic site. Therefore in these strains the oligosaccharides will mask the surface of HA as well as antigenic site. Hence 
these strains will not be recognized by host immune system.   
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Background: 
Influenza viruses pose significant challenge to both human and animal 
health. Highly pathogenic avian influenza virus infection can cause 
huge economic loss. Viruses of low virulence are changed to high 
pathogenicity when they are circulating in the poultry population due 
to high mutation rate in their genome [1]. The first outbreak of avian 
influenza A (H5N1) virus in humans occurred in Hong Kong in 1997.  
Infection was confirmed in 18 individuals, 6 of whom died. Infections 
were acquired by humans directly from chickens, without the 
involvement of an intermediate host. The outbreak was halted by a 
territory-wide slaughter of more than 1.5 million chickens at the end of 
December 1997. Influenza A virus belongs to the viral family of 
Orthomyxoviridae that have segmented, negative single-stranded sense 
RNA genome constituting envelop virion [2, 3]. Influenza A virus 
causes  epidemics and pandemics in mammals and birds. However, 
aquatic birds are natural reservoir of these viruses [4-6]. The H5N1 
sub-type is the only highly pathogenic avian viral sub-type that has 
been documented to cause an outbreak of respiratory disease in 
humans. Human influenza A virus preferentially binds to sialic acid 
linked to galactose by alpha-2,6 linkages that are mainly found on the 
epithelial cells of the human respiratory tract, whereas avian viruses 
tend to bind to alpha-2,3 linkages that are found on duck intestinal 
epithelium [7, 8]. These differences may be important in limiting the 
transfer of viruses between species. There is no evidence of human-to-
human transmission to date [9], because they cannot ‘hop’ easily 
among humans.  However, in future, this strain might acquire ability to 
spread infection among humans, either by mutation or by reassortment 
of genetic material with human influenza virus [10].  
 
Hemagglutinin (HA) is the principal antigen present on the viral 
surface. It is the primary target for neutralizing antibodies and is 
responsible for viral binding to host receptors, enabling entry into the 
host cell through endocytosis and subsequent membrane fusion. 
Earlier  in silico studies  predicted that HA of influenza A virus is 
highly sensitive to mutations and hence it is significant for its 
pathogenic nature [11].Therefore, HA is an important target for both 
drug and vaccine development. Although, 16 avian and mammalian 
serotypes of HA are known, only three (H1, H2, and H3) have become 
adapted in the human population. Five antigenic sites designated A to 
E have been located on the hemagglutinin monomer in H3N1 subtype 
[12]. Evidence suggests that single amino acid substitution within 
these five regions results in the ability of flu virus to escape immune 
surveillance and to spread infections worldwide every year. In addition 
to minor changes in the antigenic regions, major changes in the 
antigenic regions have produced the extremely virulent strains that 
caused the lethal flu pandemics in 1957 and 1968.  
 
The localization and fine structures  of two H5 antigenic sites have 
been described [13]. Site 1 is an exposed loop comprising residues 140 
to 145 (H3 numbering) that corresponds to antigenic site A of H3 [14] 
and Ca2 of H1 [15], and site 2 comprises two subsites, one (HA1 
residues 156 and 157) that corresponds to site B in the H3 subtype [14] 
and one (HA1 residues 129   to 133) that corresponds to 
immunodominant site Sa of H1 subtype [15]. Thus, HA is an 
important surface protein. Therefore, in this communication we have 
compared human   hemagglutinin protein of H5N1 influenza virus A 
of 1997 outbreak in Hong Kong with homologous HA from non-
human sources for mutations involved in change of  hydropathy-index.  
Furthermore, in all strains of non-human origins, mutations in 
antigenic sites, receptor binding site  and appearance of additional 
glycosylation site in HA have been identified which are important 
source of pathogenicity of viral infection. 
 
Methodology: 
Sequence analysis: 
The sequence of hemagglutinin of influenza A virus (bird flu virus) 
A/Hong Kong/ 156/ (H5N1) from human source was analyzed in this 
report. The protein sequence of HA is available at NCBI [16] with 
accession number [GenBank: AAC40508.1]. Protein protein Blast 
(Blast NCBI Server) [17] was performed at NCBI server, and only 
97.46 - 99.46 % similar sequences of hemagglutinin of sub-type H5N1 
were selected for the sequence analysis. The sequences of HA selected 
in this study were given in Table 1 in supplementary material. 
 
In these sequences, signal peptide segment was predicted using Signal 
P3.0 server [18].  The signal peptide segment was deleted from all 
these sequences prior to aligning using ClustalW [19] multiple 
alignment tools available at Pole Bioinformatique Lyonnais Network 
Protein Sequence analysis using weight matrix GONNET for proteins. 
These alignments were then analyzed for differences in their amino 
acids at specific positions. Hydrophobicity values were obtained from 
the tool ProtScale at ExPASy choosing Kyte & Doolittle 
hydrophobicity scale [20].  Antigenic sites in proteins were predicted 
using program Antigenic [21].  Bioinformation    open access 
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Motif prediction: 
Glycosylation motif was predicted in all protein sequences including 
A/Hong Kong/ 156/ 97 (H5N1) using Scan Prosite at Expasy Server 
[22].  
 
Discussion: 
Sequence analyses and hydrophathy-index: 
In this study, sequence analyses of HA of human and non-human 
sources showed differences in amino acid mutations at specific 
positions. In all strains like AAF02306 AAF02309, AAF02304, 
ABD14807, AAY56367 and AAO46801, V178→I178, C363→G363 
and S365→A365 mutations were found conserved (Table 2 in 
supplementary material). The AAF02306 strain showed V178→I178 
mutation, which resulted in the substitution of hydrophobic Val by 
more hydrophobic Ile. The C363→G363 mutation result  in the 
substitution of more hydrophobic Cys by less hydrophobic and small 
amino acid Gly.  Similarly, in S365 →A365 mutation, hydrophilic Ser 
is replaced by hydrophobic Ala. In AAF02309 strain besides above 
three mutations, there was one additional mutation R162→K162. This 
mutation is an example of synonymous mutation. In AAF02304 strain, 
there are two more mutations, namely A156→S156 and K368→Q368. 
Here hydrophobic Ala 156 was replaced by hydrophilic Ser 156, 
contrary to this, in other there was synonymous mutation 
(K368→Q368). Similarly, the strain ABD14807 has four additional 
mutations. Mutation K368→Q368 was found common in ABD14807 
and AAF02304 strains. The remaining three mutations in ABD14807 
strain are A156 → T156, T320→Ala320 and N387→D387.  In the 
first mutation, there was substitution of hydrophobic Ala by 
hydrophilic Thr and vice-versa in second mutation, therefore 
hydropathy-index changed.  In the last mutation, there was 
replacement of Asn by Asp causing synonymous mutation. In 
AAY56367 strain there are eight additional mutations. The 
A156→T156 and N387→ D387 mutations were found common to 
both ABD14807 and AAY56367 strains. The R35→K35 and 
N94→D94 mutations are synonymous mutations. The   I71→ T71 and 
L138→H138 mutations showed substitution of hydrophobic amino 
acid by hydrophilic amino acid. Conversly, T263→A263 mutation 
showed substitution of hydrophilic amino acid by hydrophobic amino 
acid. Finally, N409→S409 mutation showed substitution of less 
hydrophilic Asn by more hydrophilic Ser. Hence the hydropathy-index 
decreased. There are eleven additional mutations in AAO46801 strain. 
The mutations R35→K35, N94→D94, A156→T156, T263→A263 
and N387→D387 are common to both AAY56367 and AAO46801 
strains. In P217→S217 mutation, there is substitution of hydrophobic 
Pro to hydrophilic Ser. Thus, the hydropathy-index decreased. The Val 
80→G80 mutation shows substitution of more hydrophobic Val by 
less hydrophobic and small amino acid Gly. Rest of the four mutations 
is synonymous mutation. From above data, it is evident that 
V178→I178, C363→G363 and S365→A365 mutations were found 
conserved among all strains of HA. Further, it was also found that 
those mutations which changes hydropathy-index of HA, is one 
important source of pathogenesis of viral infection. The hemagglutinin 
protein shows species dependent differences.  
 
Antigenicity and receptor binding site: 
Table 3 (see supplementary material) shows the antigenicity profile 
of human hemagglutinin (AAC40508). Three potential antigenic sites   
in   non-human hemagglutinin with high   score are 171-182,543-549 
and 28-141 (Table 4 in supplementary material). Rest of the 
antigenic sites present in non-human sources are similar to human HA, 
therefore these are not shown in Table 4 in supplementary material. 
The antigenic segment comprising residues 129 to 133 correspond to 
immunodominant site SA of the H1 subtype [15]. Therefore, antigenic 
segment (128-141) predicted by computer program (Antigenic) in 
human HA is an important antigenic site. In all strains of non-human 
origin, because of two mutations C363→G363 and S365→A365, 
antigenic segment 361-366 was found missing.  In AAF02306 strain, 
Val 178 → Ile 178 mutation lies at the antigenic site predicted by 
computer program (Table 3 in supplementary material). In 
AAF02304  strain   besides V178 → Ile 178  mutation , A156→S156 
mutation  also occurred  that  lies at the antigenic subsite of site 2(HA1 
residues 156 and 157) which corresponds to site B in the H3 subtype 
[14].  Similarly, in ABD14807 strain V178 → Ile 178 and 
A156→T156 mutations occurred in antigenic sites as mentioned 
above. In AAY56367 strain, in addition to two conserved mutations 
(V178 → Ile 178, A156→S156), two more mutations were observed 
at the antigenic sites. They are mutations I71→T71 and L138→H138. 
In AAO46801 strain, three more mutations N45→D45, V80→G80 
and R140→K140 were found that lie at the antigenic sites (Table 3 in 
supplementary material). The above data conclusively showed that 
there are mutations at the antigenic sites.  Therefore, these strains will 
escape antibody binding and viral neutralization. In HA the receptor-
binding site comprises three structural elements, namely an alpha-helix 
(190-helix, HA1 188 to 190) and two loops (130-loop, HA1 134 to 
138, and 220-loop, HA1 221 to 228). Interestingly, in AAY56367 
strain   mutation L138→H138 lies at the receptor-binding site in 130-
loop.   Here, the receptor binding site also overlaps the antigenic site. 
Therefore, this amino acid substitution (L138→H138) will influence 
both the specificity of receptor recognition as well as antibody 
binding.   
 
Glycosylation site: 
There are seven potential glycosylation sites in human HA (Table 5 in 
supplementary material).   Our sequence analysis data showed that 
these glycosylation sites varied, both in number and location in 
different HA subtypes (H1 to H14) and even among variants of the 
same subtype. Similar conclusions have also been drawn in other 
studies  [23, 24]. Experiment on the natural epidemic strain A 
/VIC/3/75, which has new oligosaccharide at 63, binds antibody 
produced against 1968 strain (two epidemic earlier) when grown in 
tunicamycin and lacking the oligosaccharide at 63. This proves that 
carbohydrate, which is host specific can mask surfaces of the HA from 
the immune system [25]. Thus, the oligoscacharides present at 
glycosylation sites in human HA (Table 5 in supplementary 
material) will mask portions of the surface of human hemagglutinin; 
hence these regions will not be recognized by host immune system. 
Because of mutations, A156→S156 and A156→T156, an additional 
glycosylation site appeared at the amino acid position 154-157 in 
AAF02304  (Table 5 in supplementary material) and ABD14807, 
AAY56367, AAO46801 strains respectively. Since this glycosylation 
site is present at the antigenic site, therefore it will mask the antigenic 
segment of these strains. Hence,   hemagglutinin of these viral strains 
will be antigenically inactive and therefore will be resistant to 
antibody binding and viral neutralization.    
 
Conclusion: 
These results suggest that several factors contribute to the 
pathogenesis of viral infection. For example mutations in HA which 
changes hydropathy-index is one important source of pathogenicity. 
Other important sources of antigenic variations are mutations at the 
antigenic sites of surface viral protein hemagglutinin, addition of 
glycosylation site at the antigenic site and mutation at the receptor-
binding site. Synthetic peptides vaccines, corresponding to these 
antigenic sites should be synthesized to combat bird flu infection.   
Thus, in silico approach can serve as an important tool in delineating 
the disease pathogenesis. 
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Supplementary material 
 
Table 1: HA protein sequence dataset  
ID Sequence  name Gene Bank 
AC 
Protein 
sequence 
Place of 
isolate   Source 
1  Hemagglutinin [Influenza A virus(A/Duck/Hong Kong/p46/97 
(H5N1))]  AAF02306 552  Hong  Kong  Duck 
2  Hemagglutinin [Influenza A virus (A/Silky  Chicken/ 
HongKong/p17/97(H5N1))]  AAF02309 552  Hong  Kong  Silky 
chicken 
3  Hemagglutinin [Influenza A virus (A/Chicken/Hong Kong/y385/97 
(H5N1))]  AAF02304 552  Hong  Kong  Chicken 
4  Hemagglutinin [Influenza A virus(A/goose/Vietnam/ 3/05(H5N1))]  ABD14807  552  Vietnam  Goose 
5  Hemagglutinin [Influenza A virus (A/chicken/China/ 1/02(H5N1))]  AAY56367  552  China  Chicken 
6  Hemagglutinin [Influenza A virus (A/Pheasant/Hong Kong/FY155/01-
MB(H5N1))]  AAO46801 552  Hong  Kong  Pheasant 
 
 
Table 2: Amino acid mutations in hemagglutinin of different strains at specific positions and their physico-chemical properties 
Residue position  Residue change  Chemical property change  Hydrophobicity change 
(Kyte Doolittle) 
A/Duck/Hong Kong/p46/97  
178 V→I Hydrophobic→Hydrophobic    -1.700→-0.033 
363   C→G    Hydrophobic→Hydrophobic -0.433→-1.089 
365    S→A      Hydrophilic→Hydrophobic    -0.478→-1.133 
A/Silky Chicken/Hong Kong/ p17/97 
162 R→K Hydrophilic→Hydrophilic -0.900→-1.633 
178 V→I Hydrophobic→Hydrophobic -1.700→-0.033 
363 C→G Hydrophobic→Hydrophobic -0.433→-1.089 
365 S→A Hydrophilic→Hydrophobic -0.478→-1.133 
A/Chicken/Hong Kong/y385/97 
156 A→S     Hydrophobic→Hydrophilic    -0.000→-1.33 
178 V→I Hydrophobic→Hydrophobic -1.700→-0.03 
363 C→G Hydrophobic→Hydrophobic -0.433→-1.09 
365   S→A Hydrophilic→Hydrophobic    -0.478→-1.13 
368   K→Q   Hydrophilic→Hydrophilic   -1.11→-1.467 
A/goose/Vietnam/3/05 
156 A→T   Hydrophobic→Hydrophilic -0.000→-1.32 
178   V→I Hydrophobic→Hydrophobic -1.700→-0.033 
320   T→A Hydrophilic→Hydrophobic   -0.967→-1.767 
363   C→G Hydrophobic→Hydrophobic -0.433→-1.089 
365   S→A Hydrophobic→Hydrophobic -0.478  → 1.133 
368   K→Q Hydrophilic→Hydrophilic   -1.11→-1.467 
387   N→D Hydrophilic→Hydrophilic -1.500→-0.556 
A/chicken/China/1/02 
35 R→K Hydrophilic→Hydrophilic -0.889→-1.156 
71 I→T Hydrophobic→Hydrophilic +0.844→0.756 
94 N→D    Hydrophilic→Hydrophilic -0.756→ -1.089 
138 L→H Hydrophobic→Hydrophilic    -2.11→ -0.922 
156 A→T Hydrophobic→Hydrophilic -0.00→-1.322 
178 V→I Hydrophobic→Hydrophobic -1.70→-0.033 
263 T→A Hydrophilic→Hydrophobic -0.467→-0.567 
363 C→G Hydrophobic→Hydrophobic -0.433→-1.089 
365 S→A Hydrophilic→Hydrophobic -0.478→-1.133 Bioinformation    open access 
www.bioinformation.net    Hypothesis
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387 N→D Hydrophilic→Hydrophilic -1.500→-0.56 
409 N→S Hydrophilic→Hydrophilic -0.10→-1.811 
A/Pheasant/HongKong/FY155/01-MB 
35    R→K   Hydrophilic→Hydrophilic -0.889→-1.156 
45 N→D Hydrophilic→Hydrophilic +0.300→+0.16 
80 V→G Hydrophobic→Hydrophobic +0.233→-0.589 
94 N→D Hydrophilic→Hydrophilic -0.756→-1.089 
126 D→E Hydrophilic→Hydrophilic -0.844-→-1.344 
140 R→K Hydrophilic→Hydrophilic -1.389→+0.07 
156 A→T Hydrophobic→Hydrophilic -0.00→-1.322 
178 V→I Hydrophobic→Hydrophobic -1.700→-0.033 
212 E→K Hydrophilic→Hydrophilic -0.378→-0.100 
217 P→S Hydrophobic→Hydrophilic +0.867→-0.367 
263 T→A Hydrophilic→Hydrophobic -0.467→-0.567 
363 C→G Hydrophobic→Hydrophobic -0.433→-1.089 
365 S→A Hydrophilic→Hydrophobic -0.478→-1.133 
387 N→D Hydrophilic→Hydrophilic -1.500→ -0.556 
 
Table 3: Predicted antigenic sites in  human hemagglutinin (A/Hong Kong/156/97) 
Amino acid Position  Antigenic Segment  Total no of amino 
acid residues 
Score 
43->549 NGSLQCR  7  1.181 
128->141 SSGVSSACPYLGRS  14  1.158 
514->541 YQILSIYSTVASSLALAIMVAGLSLWMC  28  1.148 
291->315 FHNIHPLTIGECPKYVKSNRLVLAT  28  1.14 
39->60 GKLCDLNGVKPLILRDCSVAGW  22  1.135 
144->151 FRNVVWLI  8  1.132 
426->432 AELLVLM  7  1.125 
249->259 APEYAYKIVKK  11  1.112 
23->32 NVTVTHAQDI  10  1.11 
446->455 KNLYDKVRLQ  10  1.102 
206->213 NQRLVPEI  8  1.096 
100->108 ELKHLLSRI  9  1.096 
468->476 FEFYHKCDN  9  1.092 
86->93 ANDLCYPG  8  1.09 
197->203 YISVGTS  7  1.084 
418->424 FLDVWTY  7  1.079 
70->83 FINVPEWSYIVEKA  14  1.079 
361->366 GSCYSA  6  1.079 
113->120 KIQIIPKS  8  1.068 
504->509 SGVKLE  6  1.065 
488->493 DYPQYS  6  1.063 
333->339 FGAIAGF  7  1.053 
275->281 NTKCQTP  7  1.052 
187->193 QTKLYQN  7  1.026 
 
Table 4: Predicted  antigenic sites in hemagglutinin of non-human sources 
Strain Acc.No  Location  Antigenic  Segment  Score 
A/Duck/HongKong/p46/97 AAF02306 Hong  Kong  543->549  1.181 Bioinformation    open access 
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     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
A/SilkyChicken/HongKong/p17/97 AAF02309  Hong  Kong  543->549  1.181 
     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
A/Chicken/Hong Kong/y385/97 AAF02304  Hong  Kong  543->549 1.181 
     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
A/goose/Vietnam/3/05 ABD14807 Vietnam  543->549  1.181 
     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
A/chicken/China/1/02 AAY56367  China  543->549  1.181 
     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
A/Pheasant/HongKong/FY155/01-MB  AAO46801 Hong  Kong  543->549 1.181 
     128->141  1.158 
     171->178  1.15 
     361->366  (missing) 
 
Table 5:  Predicted  glycosylation site  in human hemagglutinin (A/Hong Kong/156/97(H5N1) and in non-human source(A/Chicken/Hong Kong 
/y385/97 ) 
Glycosylation Position  Glycosylation motif 
A/Hong Kong/156/97   
10 – 13  NNST 
11 – 14  NSTE 
23 – 26  NVTV 
165 – 168  NNTN 
286 – 289  NSSM 
484 – 487  NGTY 
543 – 546  NGSL 
   
A/Chicken/Hong Kong /y385/97   
10 – 13  NNST 
11 – 14  NSTE 
23 – 26  NVTV 
154– 157  NSSY 
165 – 168  NNTN 
286 – 289  NSSM 
484 – 487  NGTY 
543 – 546  NGSL 
 
 
 
 
 
 